Overlapping of Serotonin Syndrome with Neuroleptic Malignant Syndrome due to Linezolid-Fluoxetine and Olanzapine-Metoclopramide Interactions: A Case Report of Two Serious Adverse Drug Effects Caused by Medication Reconciliation Failure on Hospital Admission

被引:16
作者
Mazhar, Faizan [1 ,2 ]
Akram, Shahzad [2 ]
Haider, Nafis [1 ]
Ahmed, Rafeeque [3 ]
机构
[1] King Fahad Mil Med Complex, Prince Sultan Mil Coll Hlth Sci, Dhahran 31932, Saudi Arabia
[2] King Abdul Aziz Med City, Natl Guard Hlth Affairs, Riyadh, Saudi Arabia
[3] New York Sch Med & Dent Assistants, Long Isl City, NY USA
关键词
D O I
10.1155/2016/7128909
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Antipsychotic and antidepressant are often used in combination for the treatment of neuropsychiatric disorders. The concomitant use of antipsychotic and/or antidepressant with drugs that may interact can lead to rare, life-threatening conditions such as serotonin syndrome and neuroleptic malignant syndrome. We describe a patient who has a history of taking two offending drugs that interact with drugs given during the course of hospital treatment which leads to the development of serotonin syndrome overlapped with neuroleptic malignant syndrome. The physician should be aware that both NMS and SS can appear as overlapping syndrome especially when patients use a combination of both antidepressants and antipsychotics.
引用
收藏
页数:4
相关论文
共 18 条
[1]  
Ananth J, 2004, J CLIN PSYCHIAT, V65, P464
[2]   The evaluation and management of patients with neuroleptic malignant syndrome [J].
Bhanushali, MJ ;
Tuite, PJ .
NEUROLOGIC CLINICS, 2004, 22 (02) :389-+
[3]   The serotonin syndrome [J].
Boyer, EW ;
Shannon, M .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (11) :1112-1120
[4]   The neuroleptic malignant and serotonin syndromes [J].
Carbone, JR .
EMERGENCY MEDICINE CLINICS OF NORTH AMERICA, 2000, 18 (02) :317-+
[5]   Neuroleptic malignant syndrome after venlafaxine [J].
Cassidy, EM ;
O'Kearne, V .
LANCET, 2000, 355 (9221) :2164-2165
[6]   Ecstasy intoxication: An overlap between serotonin syndrome and neuroleptic malignant syndrome [J].
Demirkiran, M ;
Jankovic, J ;
Dean, JM .
CLINICAL NEUROPHARMACOLOGY, 1996, 19 (02) :157-164
[7]  
Dosi R., 2014, BMJ CASE REPORTS, V2014
[8]   The Hunter Serotonin Toxicity Criteria: simple and accurate diagnostic decision rules for serotonin toxicity [J].
Dunkley, EJC ;
Isbister, GK ;
Sibbritt, D ;
Dawson, AH ;
Whyte, IM .
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2003, 96 (09) :635-642
[9]   Neuroleptic malignant syndrome associated with olanzapine [J].
Filice, GA ;
McDougall, BC ;
Ercan-Eang, N ;
Billington, CJ .
ANNALS OF PHARMACOTHERAPY, 1998, 32 (11) :1158-1159
[10]   METOCLOPRAMIDE-INDUCED NEUROLEPTIC MALIGNANT SYNDROME [J].
FRIEDMAN, LS ;
WEINRAUCH, LA ;
DELIA, JA .
ARCHIVES OF INTERNAL MEDICINE, 1987, 147 (08) :1495-1497